We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KW
326
DELISTED
Kennedy-Wilson Holdings
KW
| $13.7M | 0.02% |
+873,292
| New | +$16.3M |
|
327
Range Resources
RRC
$8.85B
| $13.6M | 0.02% |
538,729
-387,946
| -42% | -$11.7M |
|
328
AES
AES
$10.6B
| $13.5M | 0.02% |
586,441
-32,426
| -5% | -$769K |
|
329
Cactus
WHD
$3.74B
| $13.1M | 0.02% |
315,188
+8,203
| +3% | +$329K |
|
330
Suncor Energy
SU
$75.6B
| $13.1M | 0.02% |
+337,088
| New | +$10.6M |
|
331
Petco
WOOF
$777M
| $13M | 0.02% |
+1,180,885
| New | +$17.3M |
|
332
Universal Health Services
UHS
$9.64B
| $12.8M | 0.02% |
140,696
-733,565
| -84% | -$75.8M |
|
333
iShares Russell 1000 Value ETF
IWD
$81.5B
| $12.7M | 0.02% |
90,626
+7,893
| +10% | +$1.19M |
|
334
Acco Brands
ACCO
$381M
| $12.5M | 0.02% |
2,587,470
-167,157
| -6% | -$1.06M |
|
|
TSE
335
DELISTED
Trinseo
TSE
| $12.4M | 0.02% |
676,254
-40,588
| -6% | -$1.27M |
|
336
Artisan Partners
APAM
$2.86B
| $12.3M | 0.02% |
450,269
-380,544
| -46% | -$13.4M |
|
337
Yelp
YELP
$1.45B
| $12.2M | 0.02% |
354,438
-487,325
| -58% | -$16.1M |
|
338
Altria Group
MO
$122B
| $12.1M | 0.02% |
299,817
-136,276
| -31% | -$5.94M |
|
|
HBI
339
DELISTED
Hanesbrands
HBI
| $11.9M | 0.02% |
1,719,093
-144,841
| -8% | -$1.42M |
|
340
Huntington Ingalls Industries
HII
$11.4B
| $11.6M | 0.02% |
51,566
-3,940
| -7% | -$884K |
|
341
ICF International
ICFI
$1.45B
| $11.6M | 0.02% |
106,118
+11,484
| +12% | +$1.16M |
|
342
QuidelOrtho
QDEL
$1.15B
| $11.4M | 0.02% |
152,448
-141,386
| -48% | -$12.6M |
|
|
PETQ
343
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $11.2M | 0.02% |
1,574,385
-43,222
| -3% | -$583K |
|
344
Standard Motor Products
SMP
$867M
| $11.1M | 0.02% |
331,478
+37,116
| +13% | +$1.48M |
|
|
HOUS
345
DELISTED
Anywhere Real Estate
HOUS
| $11M | 0.02% |
1,406,916
-509,404
| -27% | -$5.22M |
|
|
NESR
346
National Energy Services Reunited Corp
NESR
$2.71B
| $10.9M | 0.02% |
1,789,441
-59,255
| -3% | -$398K |
|
347
Navient
NAVI
$809M
| $10.8M | 0.02% |
738,303
-1,562,773
| -68% | -$23.9M |
|
348
Chemed
CHE
$6.76B
| $10.8M | 0.02% |
24,457
+850
| +4% | +$409K |
|
349
Lithia Motors
LAD
$7.88B
| $10.7M | 0.02% |
50,139
-2,983
| -6% | -$779K |
|
350
First Horizon
FHN
$12.1B
| $10.6M | 0.02% |
457,276
-24,728
| -5% | -$562K |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.